Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank57
3Y CAGR+28.5%
5Y CAGR+73.3%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+28.5%/yr
vs +391.5%/yr prior
5Y CAGR
+73.3%/yr
Recent deceleration
Acceleration
-362.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
15.6x
Strong expansion
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.19M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $2.92M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $396000.00 | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $5000.00 | -100.0% |
| 2017 | $616.00M | -1.4% |
| 2016 | $625.00M | - |